Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.11.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BZ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.10.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BA.5.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.44ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used